Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. Invited commentary.
Butterworth
John
J
Department of Anesthesia, Indiana University School of Medicine, 204 South Dr, FH 204, Indianapolis, IN 46202, USA. jfbutter@iupui.edu
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001120:Arginine / Q000031:analogs & derivatives; D001323:Autoantibodies / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006353:Heart-Assist Devices; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007262:Infusions, Intravenous; D051741:Kruppel-Like Transcription Factors / Q000276:immunology; D010875:Pipecolic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D011183:Postoperative Complications / Q000139:chemically induced* / Q000188:drug therapy / Q000401:mortality; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D011474:Prosthesis Design; D012097:Repressor Proteins / Q000276:immunology; D012189:Retrospective Studies; D012307:Risk Factors; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy
D000925:Anticoagulants; D001323:Autoantibodies; D051741:Kruppel-Like Transcription Factors; D010875:Pipecolic Acids; D012097:Repressor Proteins; D013449:Sulfonamides; C115768:ZNF85 protein, human; D006493:Heparin; D001120:Arginine; D013917:Thrombin; C031942:argatroban